These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16770735)

  • 1. Evidence that plasmalogen is protective against oxidative stress in the rat brain.
    Kuczynski B; Reo NV
    Neurochem Res; 2006 May; 31(5):639-56. PubMed ID: 16770735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of myo-inositol and plasmalogen metabolism in rat brain.
    Hoffman-Kuczynski B; Reo NV
    Neurochem Res; 2004 Apr; 29(4):843-55. PubMed ID: 15098950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of myo-inositol plus ethanolamine elevates phosphatidylethanolamine plasmalogen in the rat cerebellum.
    Hoffman-Kuczynski B; Reo NV
    Neurochem Res; 2005 Jan; 30(1):47-60. PubMed ID: 15756932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Myo-inositol Plus Ethanolamine on Plasmalogens and Cell Viability during Oxidative Stress.
    Sibomana I; Grobe N; DelRaso NJ; Reo NV
    Chem Res Toxicol; 2019 Feb; 32(2):265-284. PubMed ID: 30604967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers.
    Maeba R; Araki A; Fujiwara Y
    Adv Clin Chem; 2018; 87():69-111. PubMed ID: 30342713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of plasmalogen in the oxidative stability of neutral lipids and phospholipids.
    Wang G; Wang T
    J Agric Food Chem; 2010 Feb; 58(4):2554-61. PubMed ID: 20099826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates.
    Stadelmann-Ingrand S; Pontcharraud R; Fauconneau B
    Chem Phys Lipids; 2004 Aug; 131(1):93-105. PubMed ID: 15210368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats.
    Nishimukai M; Yamashita M; Watanabe Y; Yamazaki Y; Nezu T; Maeba R; Hara H
    Eur J Nutr; 2011 Sep; 50(6):427-36. PubMed ID: 21152926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats.
    Mawatari S; Katafuchi T; Miake K; Fujino T
    Lipids Health Dis; 2012 Nov; 11():161. PubMed ID: 23170810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.
    Ullen A; Fauler G; Köfeler H; Waltl S; Nusshold C; Bernhart E; Reicher H; Leis HJ; Wintersperger A; Malle E; Sattler W
    Free Radic Biol Med; 2010 Dec; 49(11):1655-65. PubMed ID: 20807565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes.
    Stadelmann-Ingrand S; Favreliere S; Fauconneau B; Mauco G; Tallineau C
    Free Radic Biol Med; 2001 Nov; 31(10):1263-71. PubMed ID: 11705705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against a major role of plasmalogens in the resistance of astrocytes in lactic acid-induced oxidative stress in vitro.
    Fauconneau B; Stadelmann-Ingrand S; Favrelière S; Baudouin J; Renaud L; Piriou A; Tallineau C
    Arch Toxicol; 2001 Jan; 74(11):695-701. PubMed ID: 11218046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease.
    Guan Z; Wang Y; Cairns NJ; Lantos PL; Dallner G; Sindelar PJ
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):740-7. PubMed ID: 10411344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmalogens: targets for oxidants and major lipophilic antioxidants.
    Engelmann B
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):147-50. PubMed ID: 14748736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hexachlorocyclohexane-induced neuronal oxidative stress by natural antioxidants.
    Srivastava A; Shivanandappa T
    Nutr Neurosci; 2014 Jul; 17(4):164-71. PubMed ID: 24257078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen.
    Pettegrew JW; Panchalingam K; Levine J; McClure RJ; Gershon S; Yao JK
    Biol Psychiatry; 2001 Mar; 49(5):444-53. PubMed ID: 11274656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of plasmenylcholine with free radicals in selected model systems.
    Broniec A; Żądło A; Pawlak A; Fuchs B; Kłosiński R; Thompson D; Sarna T
    Free Radic Biol Med; 2017 May; 106():368-378. PubMed ID: 28232206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.
    Aly HF; Metwally FM; Ahmed HH
    Acta Biochim Pol; 2011; 58(4):513-20. PubMed ID: 22146133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.
    Khan M; Singh J; Singh I
    J Neurochem; 2008 Aug; 106(4):1766-79. PubMed ID: 18540993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage.
    Prigol M; Wilhelm EA; Schneider CC; Nogueira CW
    Chem Biol Interact; 2008 Nov; 176(2-3):129-36. PubMed ID: 18722362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.